Blue Horseshoe Stocks: PBR Options Recap & More

Petroleo Brasileiro SA (Petrobras) PBR – Recap

Yesterday morning, one of the primary focal points our premarket report was a pair of PBR options contracts, the PBR Weekly $14 & 14.50 Calls.

We cited the stock’s volatility and rapid rise over recent relative lows as the reasons for our interest, and despite yet another reversal for the markets in general, we got very solid single-session results for our PBR ideas. The $14′s traded up 95% from .21-.41, while the $14.50′s logged a double-bagger as they ran from  .05-.11, a gain of 120%

PBR is gapping up once again this morning, so we expect these figures to open up even higher. We will then be looking for a possible dip-and-rip scenario.


BioXcel Therapeutics, Inc. BTAI

We mentioned BTAI for the first time in yesterday morning’s extended watchlist, and got a solid first day performance from that stock as well, as it went in the books as the 2nd highest gainer on the Nasdaq for the session.

From a low of 4.00, BTAI went on to hit a high of 5.84, which worked out to a respectable 46% rise that also bucked the overall trend of the day. The move was facilitated by news that the company achieved positive human proof-of-concept data for acute treatment of agitation in patients with Alzheimer’s Disease, and other degenerative neural disorders. (>>View PR)


Extended Watchlist:
W, APU, ARGX, MYSZ, SN, XPO, EPZM, AMID, PROP, SING

Blue Horseshoe Stocks: GW Pharma & More


Eagle Bancorp, Inc. EGBN

After realizing that EGBN had been the target of dishonest short-seller tactics, we tagged some options ideas on the morning of December 5th – the EGBN 12/15 $50-60 Calls. The stock had been absolutely hammered in the previous session.

We saw some really nice moves from those contracts when EGBN immediately began to rebound ranging from 73-200% The stock dealt with some resistance over the later portion of last week and into this Monday, but managed to continue its recovery and go on to set another new high yesterday.

That produced another opportunity in a couple of the contracts we highlighted, with the $55 Calls trading from 1.20-4.40 for a 267% swing, and the $60′s exploding for a 600% rip from .10 to .70.


GW Pharmaceuticals plc GWPH
.
We’re looking at a familiar cannabis stock in GWPH this morning as the company is receiving some positive attention over its announcement that it had reacquired the rights to develop Sativex, a 1:1 THC/CBD extract blend oral spray product.

The stock is seeing some bullish premarket activity, and we’re going to signal a pair of corresponding quick strike options calls. We’ll be looking for a dip and rip scenario, and tracking the relation activity in the GWPH Weekly $125 & $130 Calls.


Extended Watchlist:
ARGX, CLRB, TANH, MYO, MRNS, BIOA, DRRX